Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 434,000 | 273,000 | 464,000 | 135,000 | 263,000 |
| Receivables | 1,117,000 | 1,088,000 | 1,079,000 | 1,012,000 | 1,097,000 |
| Inventories | 112,000 | 105,000 | 98,000 | 99,000 | 95,000 |
| TOTAL | $1,779,000 | $1,566,000 | $1,778,000 | $1,390,000 | $1,603,000 |
| Non-Current Assets | |||||
| PPE Net | 1,351,000 | 1,307,000 | 1,277,000 | 1,288,000 | 1,194,000 |
| Investments And Advances | 474,000 | 458,000 | 454,000 | 436,000 | 456,000 |
| Intangibles | 7,755,000 | 7,777,000 | 7,805,000 | 7,770,000 | 7,615,000 |
| Other Non-Current Assets | 660,000 | 652,000 | 623,000 | 119,000 | 118,000 |
| TOTAL | $10,240,000 | $10,194,000 | $10,159,000 | $9,613,000 | $9,383,000 |
| Total Assets | $12,019,000 | $11,760,000 | $11,937,000 | $11,003,000 | $10,986,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 805,000 | 807,000 | 1,108,000 | 464,000 | 304,000 |
| Accounts payable and accrued liabilities | 1,059,000 | 951,000 | 1,029,000 | 1,021,000 | 1,085,000 |
| TOTAL | $2,011,000 | $1,904,000 | $2,282,000 | $1,485,000 | $1,389,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,188,000 | 3,169,000 | 3,131,000 | 3,429,000 | 3,394,000 |
| aiOther Non-Current Liabilities | 1,155,000 | 1,165,000 | 1,171,000 | 810,000 | 824,000 |
| TOTAL | $4,354,000 | $4,347,000 | $4,314,000 | $4,251,000 | $4,232,000 |
| Total Liabilities | $6,365,000 | $6,251,000 | $6,596,000 | $5,736,000 | $5,621,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 134,697 | 134,670 | 134,375 | 134,262 | 136,072 |
| Common Shares | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
| Retained earnings | 7,992,000 | 7,849,000 | 7,694,000 | 7,602,000 | 7,546,000 |
| Other shareholders' equity | -6,000 | -8,000 | -4,000 | -8,000 | -10,000 |
| TOTAL | $5,654,000 | $5,509,000 | $5,341,000 | $5,267,000 | $5,365,000 |
| Total Liabilities And Equity | $12,019,000 | $11,760,000 | $11,937,000 | $11,003,000 | $10,986,000 |